Patents Represented by Attorney, Agent or Law Firm Paul R. Cantrell
-
Patent number: 6322998Abstract: The present invention provides DNA compounds that encode ACV synthetase activity of Cephalosporium acremonium. The compounds can be used to construct recombinant DNA expression vectors for a wide variety of host cells, including E. coli, Penicillium, Cephalosporium, and Aspergillus.Type: GrantFiled: October 29, 1992Date of Patent: November 27, 2001Assignee: Eli Lilly and CompanyInventors: Cathleen A. Cantwell, Roland L. Hodges, JoAnn Hoskins, Stephen W. Queener, Paul L. Skatrud
-
Patent number: 6008041Abstract: The present invention provides the cDNA sequence encoding bovine dipeptidylaminopeptidase 1. The invention demonstrates that bovine DAP 1 coded by a single cDNA. The mature protein is derived from a single polypeptide consisting of a signal peptide, and a major polypeptide which is processed to generate the a subunit, b subunit and g subunit.Type: GrantFiled: May 2, 1997Date of Patent: December 28, 1999Assignee: Eli Lilly and CompanyInventors: Christopher Carl Frye, Charles Lee Hershberger, Haichao Zhang
-
Patent number: 5945320Abstract: A DNA molecule isolated from Streptomyces ambofaciens encodes the multi-functional proteins which direct the synthesis of the polyketide platenolide.Type: GrantFiled: February 21, 1997Date of Patent: August 31, 1999Assignee: Eli Lilly and CompanyInventors: Stanley G. Burgett, Stuart A. Kuhstoss, Ramachandra N. Rao, Mark A. Richardson, Paul R. Rosteck, Jr.
-
Patent number: 5876991Abstract: A DNA molecule isolated from Streptomyces fradiae encodes the multi-functional proteins which direct the synthesis of the polyketide tylactone.Type: GrantFiled: February 21, 1997Date of Patent: March 2, 1999Assignee: Eli Lilly and CompanyInventors: Bradley S. DeHoff, Stuart A. Kuhstoss, Paul R. Rosteck, Jr., Kimberly L. Sutton
-
Patent number: 5874103Abstract: An aqueous base suspension concentrate of an ionophore antibiotic or ionophore antibiotics capable of aqueous dilution (if desired) and capable (with or without such aqueous dilution) of being orally administered to an animal (eg; by drenching), said concentration comprising(I) at least one ionophore antibiotic in (II) an aqueous system containing( ) a wetting and/or surfactant agent(ii) an antifreeze agent or agents in which the ionophore antibiotic or antibiotics is or are no more than sparingly soluble,(iii) a suspension agent,(iv) optionally an antifoam agent or system,(v) optionally a preservative,(vi) optionally a de-bittering agent,(vii) optionally a pH buffering system, and(viii) water.Type: GrantFiled: July 23, 1996Date of Patent: February 23, 1999Assignee: Eli Lilly and CompanyInventors: Derek George Moore, Lionel Barry Lowe, Kevin Charles Palmer, Kim Ewing Melville Agnew
-
Patent number: 5824496Abstract: The present invention provides a method for preventing the accumulation of aberrant expression vectors during fermentation processes which rely on the expression of an expression vector coded gene for production of a polypeptide product of interest. Antibiotics are added at approximately the time at which product expression begins.Type: GrantFiled: August 10, 1995Date of Patent: October 20, 1998Assignee: Eli Lilly and CompanyInventor: William L. Muth
-
Patent number: 5821331Abstract: The present invention provides a group of novel compounds that inhibit the proteolytic activity of 3C proteases which are found in picornaviruses, particularly rhinoviruses. In picornaviruses the RNA genome is translated into a single large viral polyprotein precursor. The precursor demonstrates auto-proteolytic activity, cleaving itself into mature viral gene products. Therefore, compounds of the current invention are particularly useful in treating picornaviral infections by interrupting the processing of the viral gene products into mature and infectious viral particles. The current invention also provides a novel process the preparation of compounds of the current invention. The process entails the selective reduction of an imide intermediate representing a marked improvement over processes known in the art for making peptidyl-aldehydes.Type: GrantFiled: February 8, 1996Date of Patent: October 13, 1998Assignee: Eli Lilly and CompanyInventors: Marlys Hammond, Stephen W. Kaldor
-
Patent number: 5714363Abstract: Deacetoxycephalosporin C hydroxylase is obtained in purified form from crude cell-free extracts via chromatography over a weak anionic exchange resin, ammonium sulfate fractionation, gel filtration, hydroxylapatite chromatography, and FPLC. The enzyme is obtained in >90% purity by further gel filtration and a second FPLC. The 28-residue amino-terminal sequence of hydroxylase is provided as well as a 9-residue amino-terminal sequence of an internal sequence and a 3-residue carboxy-terminal sequence. In addition to the efficient conversion of DAOC to DAC, the hydroxylase provided herein converts 7.beta.-(.alpha.-aminoadipamido)-3-exomethylenecepham-4-carboxylic acid to DAC.Type: GrantFiled: April 23, 1992Date of Patent: February 3, 1998Assignee: Eli Lilly and CompanyInventors: Wu-Kuang Yeh, Joe E. Dotzlaf
-
Patent number: 5691385Abstract: .beta.-Phenethanolamines are effective in promoting growth and improving feed efficiency and leanness in animals.Type: GrantFiled: May 25, 1995Date of Patent: November 25, 1997Assignee: Eli Lilly and CompanyInventors: David B. Anderson, Klaus K. Schmiegel, Edward L. Veenhuizen
-
Patent number: 5686413Abstract: Combined administration of a growth hormone related substance and ractopamine, cimaterol, clenbuterol, L-644,969, or albuterol to swine provides improved growth feed efficiency, and carcass quality. Administration of ractopamine, cimaterol, clenbuterol, L-644,969, or albuterol to swine that also receive growth hormone related substance reduces greater than normal blood sugar and insulin levels.Type: GrantFiled: June 5, 1995Date of Patent: November 11, 1997Assignee: Eli Lilly and CompanyInventors: David B. Anderson, D. Jay Jones, Alvin L. Melliere
-
Patent number: 5677423Abstract: A process for removing .beta.-hydroxy groups from .beta.-hydroxy-containing compounds is disclosed. The process involves the use of a retro-aldol-promoting reagent selected from the group of trimethylamine-N-oxide, triethylamine-N-oxide, trimethylamine-N-oxide-hydrate, and trimethylamine-hydrate and requires dissolution of the substrate in an aprotic solvent and reaction under elevated temperatures. The process is broadly applicable to a variety of substrates including complex cyclic peptides, linear peptides, and non-peptides.Type: GrantFiled: December 10, 1996Date of Patent: October 14, 1997Assignee: Eli Lilly and CompanyInventor: Michael J. Rodriguez
-
Patent number: 5670485Abstract: The present invention is directed to anticoccidial methods, animal feed premixes, and animal feeds, employing a specified o-phenylenediamine or benzimidazole. The present invention is also directed to anticoccidial methods, animal feed premixes, and animal feeds employing two active agents. In such combined therapy, a first substance is a polyether antibiotic, and the second substance is a designated, benzimidazoline.Type: GrantFiled: April 21, 1995Date of Patent: September 23, 1997Assignee: Eli Lilly and CompanyInventor: George O. P. O'Doherty
-
Patent number: 5658755Abstract: Heterologous extra-cellular expression of recombinant proteins in soluble functional form is desirable because of the ease associated with purification of the secreted proteins and avoidance of the need for cell extraction and protein refolding procedures. The present invention provides DNA sequences of the naturally-occurring phthalyl amidase gene isolated from Xanthobacter agilis that control transcription, translation, and extra-cellular secretion of proteins in Streptomyces lividans. These DNA sequences can be used in a method for extra-cellular expression of a wide variety of proteins in soluble functional form.Type: GrantFiled: July 15, 1994Date of Patent: August 19, 1997Assignee: Eli Lilly and CompanyInventors: Stephen W. Queener, Joseph M. Zock
-
Patent number: 5650397Abstract: The present invention is directed to anticoccidial methods, animal feed premixes, and animal feeds, employing a specified o-phenylenediamine or benzimidazole. The present invention is also directed to anticoccidial methods, animal feed premixes, and animal feeds employing two active agents. In such combined therapy, a first substance is a polyether antibiotic, and the second substance is a designated o-phenylenediamine, benzimidazole, or benzimidazoline.Type: GrantFiled: April 21, 1995Date of Patent: July 22, 1997Assignee: Eli Lilly and CompanyInventor: George O. P. O'Doherty
-
Patent number: 5646275Abstract: 7.beta.-Amino-3-hydroxy-1-carba(1-dethia)-3-cephem-4-carboxylic acid esters are provided via cyclization of compounds of Formula IIA below. ##STR1## The 7.beta.-Amino-3-hydroxy-l-carba(1-dethia)-3-cephem-4-carboxylic acid esters are useful chiral intermediates in the synthesis of .beta.-lactam antibiotics.Type: GrantFiled: April 25, 1995Date of Patent: July 8, 1997Assignee: Eli Lilly and CompanyInventors: John P. Gardner, Billy G. Jackson
-
Patent number: 5643967Abstract: .beta.-Phenethanolamines are effective in promoting growth and improving feed efficiency and leanness in animals.Type: GrantFiled: March 18, 1993Date of Patent: July 1, 1997Assignee: Eli Lilly and CompanyInventors: David B. Anderson, Klaus K. Schmiegel, Edward L. Veenhuizen, Ronald R. Tuttle
-
Patent number: 5637603Abstract: The present invention is directed to the use of disulfonyl methane compounds for the control of parasites in vertebrate animals.Type: GrantFiled: April 25, 1995Date of Patent: June 10, 1997Assignee: Eli Lilly and CompanyInventor: David I. Wickiser
-
Patent number: 5635216Abstract: A composition of polyester microparticles containing bioactive polypeptide agents and methods for preparing the composition and administering bioactive agents. The composition comprises biocompatible, biodegradable microparticles having a polyester matrix and from about 5% to about 25% by weight of a biologically active, water-soluble polypeptide dispersed throughout the matrix, the polypeptide selected from the group consisting of growth hormone releasing factor, synthetic analogs of growth hormone releasing factor, pharmacologically active fragment thereof and somatogenin. The method for preparing the composition includes dissolving polyester in an organic solvent; suspending a biologically active agent in the polyester solution; emulsifying the suspension into an aqueous medium in which the agent is insoluble and evaporating the solvent from the emulsion to produce microparticles.Type: GrantFiled: December 16, 1993Date of Patent: June 3, 1997Assignee: Eli Lilly and CompanyInventor: William W. Thompson
-
Patent number: 5635490Abstract: The present invention is directed to anticoccidial methods, animal feed premixes, and animal feeds, employing a specified o-phenylenediamine or benzimidazole. The present invention is also directed to anticoccidial methods, animal feed premixes, and animal feeds employing two active agents. In such combined therapy, a first substance is a polyether antibiotic, and the second substance is a designated o-phenylenediamine, benzimidazole, or benzimidazoline.Type: GrantFiled: May 26, 1995Date of Patent: June 3, 1997Assignee: Eli Lilly and CompanyInventor: George O. P. O'Doherty
-
Patent number: 5631298Abstract: .beta.-Phenethanolamines are effective in promoting growth and improving feed efficiency and leanness in animals.Type: GrantFiled: May 25, 1995Date of Patent: May 20, 1997Assignee: Eli Lilly and CompanyInventors: David B. Anderson, Edward L. Veenhuizen